日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Virulence on Pm4 kinase-based resistance is determined by two divergent wheat powdery mildew effectors

基于Pm4激酶的抗性毒力由两种不同的小麦白粉病效应因子决定。

Bernasconi, Zoe; Herger, Aline G; Caro, Maria Del Pilar; Kunz, Lukas; Müller, Marion C; Stirnemann, Ursin; Outram, Megan A; Widrig, Victoria; Neidhart, Matthias; Isaksson, Jonatan; Schudel, Seraina; Rösli, Sebastian; Wicker, Thomas; Bender, Kyle W; Zipfel, Cyril; Dodds, Peter N; Figueroa, Melania; Sánchez-Martín, Javier; Keller, Beat

Single-Step Extrusion Printing of Microgrooved Annulus Fibrosus Scaffolds via Patterned Nozzles

利用图案化喷嘴一步挤出打印微槽纤维环支架

Kluser, Nadine; Alig, Gion Ursin; Sprecher, Christoph; Woods, Xavier; Grad, Sibylle; Alini, Mauro; Häckel, Sonja; Albers, Christoph E; Eglin, David; Narayanan, Rajkishen; Vernengo, Andrea J

Changes in 1-year relative survival of patients with cancer during the COVID-19 pandemic in Denmark, Finland, Iceland, Norway, and Sweden: A population-based cohort study

丹麦、芬兰、冰岛、挪威和瑞典癌症患者在 COVID-19 大流行期间 1 年相对生存率的变化:一项基于人群的队列研究

Yli-Mäyry, Fernando Gonzalez; Tanskanen, Tomas; Seppä, Karri; Johansson, Anna L V; Skovlund, Charlotte Wessel; Mørch, Lina Steinrud; Friis, Søren; Kønig, Simon Mathis; Johannesen, Tom Børge; Myklebust, Tor Åge; Pejicic, Sasha; Pettersson, David; Guðmundsdóttir, Eva María; Heinävaara, Sirpa; Malila, Nea; Miettinen, Joonas; Ahlgren, Johan; Ursin, Giske; Pitkäniemi, Janne

Anti-Her2 therapy patterns in metastatic breast cancer-Real-world data suggest undertreatment

转移性乳腺癌抗HER2治疗模式——真实世界数据表明治疗不足

Vandraas, Kathrine F; Hjorth, Sarah; Trewin-Nybråten, Cassia B; Ursin, Giske; Botteri, Edoardo; Andreassen, Bettina Kulle; Reinertsen, Kristin V; Blix, Egil S; Naume, Bjørn; Støer, Nathalie C

Quality-adjusted life years in the presence and absence of organized mammographic screening using data from BreastScreen Norway

利用挪威乳腺癌筛查项目的数据,分析在有无组织化乳腺X线筛查的情况下,质量调整生命年(QALY)的变化。

Groeneweg, Rick; van Ravesteyn, Nicolien T; Kregting, Lindy M; Ursin, Giske; Hofvind, Solveig; Moshina, Nataliia

Anti-HER2 treatment in everyday practice: how we treat older women with breast cancer differently

日常实践中的抗HER2治疗:我们如何区别对待老年乳腺癌患者

Hjorth, S; Vandraas, K F; Trewin-Nybråten, C B; Botteri, E; Ursin, G; Andreassen, B K; Støer, N C

Large language models for surgical informed consent: an ethical perspective on simulated empathy

用于手术知情同意的大型语言模型:模拟同理心的伦理视角

Rudra, Pranab; Balke, Wolf-Tilo; Kacprowski, Tim; Ursin, Frank; Salloch, Sabine

BATF2 is a glutamine-responsive tumour suppressor required for type-I interferon-dependent anti-tumour immunity.

BATF2 是一种谷氨酰胺反应性肿瘤抑制因子,是 I 型干扰素依赖性抗肿瘤免疫所必需的。

Gong Wang, Taner Hülya F, Wu Yuesong, He Yumin, Zhou Xingwu, Li Zaiye, Hu Xin, Ursin Charisse, Debnath Kala Chand, Okuyama Kohei, Hu Qiang, Donnelly Christopher R, Nör Felipe, Perera Chamila D, Bellile Emily, Yunesi Arash, Zhai Zhiqian, Zhao Mei, Cheng Wanqing, Fitzsimonds Zackary R, Broses Luke, Li Jiaqian, Demehri Shadmehr, Nagrath Deepak, Wolf Gregory T, Sikora Andrew G, Yu Yanbao, Wen Haitao, Wei Lei, Chinn Steven B, Myers Jeffrey N, Akira Shizuo, Xie Yuying, Moon James J, Lei Yu Leo

Aprepitant use during chemotherapy and association with survival in women with early breast cancer

阿瑞匹坦在化疗期间的应用与早期乳腺癌女性患者的生存率相关

Botteri, Edoardo; Hjorth, Sarah; Conforti, Fabio; Bagnardi, Vincenzo; Andreassen, Bettina K; Støer, Nathalie C; Bhargava, Sameer; Ursin, Giske; Gandini, Sara; Sloan, Erica K; Chang, Aeson

Correction: Menopausal hormone therapy and breast cancer risk: a population-based cohort study of 1.3 million women in Norway

更正:更年期激素疗法与乳腺癌风险:一项基于挪威130万女性的人群队列研究

Støer, Nathalie C; Vangen, Siri; Singh, Deependra; Fortner, Renée T; Hofvind, Solveig; Ursin, Giske; Botteri, Edoardo